A phase 2b randomized, controlled trial of the efficacy of the GMZ2 malaria vaccine in African children

Author:

Sirima Sodiomon B.,Mordmüller Benjamin,Milligan Paul,Ngoa Ulysse Ateba,Kironde Fred,Atuguba Frank,Tiono Alfred B.,Issifou Saadou,Kaddumukasa Mark,Bangre Oscar,Flach Clare,Christiansen Michael,Bang Peter,Chilengi Roma,Jepsen Søren,Kremsner Peter G.,Theisen Michael,Ouédraogo Alphonse,Kargougou Désiré,Nébié Issa,Débé Siaka,Diarra Amidou,Bougouma Edith,Hounkpatin Aurore B.,Adegnika Ayola Akim,Lell Bertrand,Joanny Fanny,Honkpehedji Yabo Josiane,Agobe Jean Claude Dejon,Esen Meral,Ajua Anthony,Asoala Victor,Anyorigiya Thomas,Ansah Nana Akosua,Buwembo William,Mworozi Edison,Sekikubo Musa,Abubakar Ismaela,Bojang Kalifa,Noor Ramadhani,Okech Brenda,Ejigu Dawit A.

Funder

European and Developing Countries Clinical Trials Partnership

German Federal Ministry of Education and Research

European Malaria Vaccine Initiative

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3